SEC Filing Summary: BP PLC
Business Context and Reporting Period
The provided filing is a Form 13F Information Table submitted to the U.S. Securities and Exchange Commission. The metadata indicates a reporting period of March 31, 2026, for BP PLC. However, the actual content of the filing text describes a holding in CME Group Inc., not BP PLC's own financial results.
Financial Metrics
The filing text does not provide revenue, profit, cash flow, margins, debt, or liquidity metrics for BP PLC. Form 13F filings report institutional investment holdings rather than the issuer's operational financial performance.
Material Changes
No material changes regarding BP PLC's operations or financial position are disclosed in this text. The document lists a specific investment position held by a reporting manager:
- Issuer: CME Group Inc.
- Security: Common Stock (CUSIP: 12572Q105)
- Shares Held: 60,000
- Value: $17,721,000
- Voting Authority: Sole
Guidance, Outlook, and Risks
The filing text contains no management commentary, guidance, outlook, risk factors, or contingencies related to BP PLC. It is a regulatory disclosure of a portfolio holding.
Key Facts for Investor Verification
- The document is a Form 13F, which discloses holdings of institutional investment managers, not the financial statements of BP PLC.
- The text details a $17.7 million position in CME Group Inc., not BP PLC.
- No financial performance data (revenue, earnings, cash flow) for BP PLC is present in this specific filing text.
- Investors should verify the identity of the reporting manager and cross-reference with BP PLC's official 10-K or 10-Q filings for operational metrics.